Skip to main content
See the bias in every story
Published • loading... • Updated

Lactation Drug Cabergoline May Reduce Breast Cancer Risk in Mothers

Summary by News Medical
An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth.

14 Articles

Center

The potential preventive effect will still need to be demonstrated through clinical trials.

·Madrid, Spain
Read Full Article
Lean Right

A team from the Cancer Research Center shows that a dose of cabergoline given after breast-feeding strengthens protection against breast cancer

·Madrid, Spain
Read Full Article

Cabergoline has halved the occurrence of tumours in mice and is associated with a lower risk in medical records of more than 150,000 women in Spain and Norway

A study published on October 15, 2026 associated cabergoline with 70% less risk of breast cancer in women in Spain and Norway. It still requires clinical trials.

·Lima, Peru
Read Full Article

According to research from the Salamanca Cancer Center

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

noticiasdealava.eus broke the news on Thursday, October 15, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal